• Molecular NameTasosartan
  • SynonymNA
  • Weight411.469
  • Drugbank_IDDB01349
  • ACS_NO145733-36-4
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.1
  • pkaN/A
  • LogD (pH=7, predicted)0.55
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.85
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors1
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds4
  • TPSA100.55
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn angiotensin II receptor antagonist.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability50.0
  • Protein binding99.5
  • Volume of distribution (VD)500 L.
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life24 h.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A